In another study, using WES, considerable tumor heterogeneity, mediated by EGRF overexpression, was observed in GBM, as well as a deletion on chromosome 10, losing phosphatase and tensin homolog (PTEN) and cyclin-dependant kinase inhibitor 2A (CDKN2A) genes (57). This evidence concerns the gene PTEN and glioblastoma.